Nature Communications (Jan 2021)
Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients
Abstract
The detection of aberrations in circulating tumour DNA represents a non-invasive method to survey the oncogenes and tumour suppressors that are modified within a patient’s cancer. Here, the authors analysed more than 10,000 patients using a targeted sequencing panel and report on the frequencies of the mutations that they found.